Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Hematopoietic recovery by ASXL1-mutated clones after immune suppressive therapy in a patient with severe aplastic anemia].
Shimizu Y, Nishikii H, Iitsuka T, Matsuoka R, Kurita N, Sakamoto T, Yokoyama Y, Kato T, Suehara Y, Hattori K, Maruyama Y, Nannya Y, Ogawa S, Sakata-Yanagimoto M, Chiba S, Obara N. Shimizu Y, et al. Among authors: obara n. Rinsho Ketsueki. 2023;64(1):49-53. doi: 10.11406/rinketsu.64.49. Rinsho Ketsueki. 2023. PMID: 36775307 Japanese.
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial.
Röth A, Ichikawa S, Ito Y, Kim JS, Nagy Z, Obara N, Panse J, Schrezenmeier H, Sica S, Soret J, Usuki K, Yoon SS, Balachandran N, Buri M, Lundberg P, Patel H, Shinomiya K, Sostelly A, Nishimura JI. Röth A, et al. Among authors: obara n. Eur J Haematol. 2023 Aug;111(2):300-310. doi: 10.1111/ejh.14011. Epub 2023 Jun 15. Eur J Haematol. 2023. PMID: 37321625 Clinical Trial.
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
Kurita N, Nishikii H, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Kato T, Yokoyama Y, Obara N, Maruo K, Ohigashi T, Yamaguchi H, Iwamoto T, Minohara H, Matsuoka R, Hashimoto K, Sakata-Yanagimoto M, Chiba S. Kurita N, et al. Among authors: obara n. Ann Hematol. 2023 Oct;102(10):2895-2902. doi: 10.1007/s00277-023-05410-3. Epub 2023 Aug 17. Ann Hematol. 2023. PMID: 37589942 Clinical Trial.
[Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation].
Momose H, Kurita N, Nishikii H, Yusa N, Yokoyama K, Shimizu E, Imoto S, Nanmoku T, Maruyama Y, Sakamoto T, Yokoyama Y, Kato T, Matsuoka R, Obara N, Sakata-Yanagimoto M, Chiba S. Momose H, et al. Among authors: obara n. Rinsho Ketsueki. 2024;65(1):35-40. doi: 10.11406/rinketsu.65.35. Rinsho Ketsueki. 2024. PMID: 38311387 Japanese.
[Acute myeloid leukemia harboring NUP98::DDX10].
Kurita N, Kato T, Nanmoku T, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Yokoyama Y, Yoshida C, Tsuboi Y, Obara N, Nishikii H, Sakata-Yanagimoto M, Chiba S. Kurita N, et al. Among authors: obara n. Rinsho Ketsueki. 2022;63(10):1397-1401. doi: 10.11406/rinketsu.63.1397. Rinsho Ketsueki. 2022. PMID: 36351646 Japanese.
239 results